InvestorsObserver
×
News Home

Is BioDelivery Sciences International, Inc. (BDSI) a Good Buy in the Biotechnology Industry?

Thursday, March 11, 2021 12:05 PM | InvestorsObserver Analysts

Mentioned in this article

Is BioDelivery Sciences International, Inc. (BDSI) a Good Buy in the Biotechnology Industry?

BioDelivery Sciences International, Inc. (BDSI) is around the middle of the Biotechnology industry according to InvestorsObserver. BDSI received an overall rating of 47, which means that it scores higher than 47 percent of all stocks. BioDelivery Sciences International, Inc. also achieved a score of 61 in the Biotechnology industry, putting it above 61 percent of Biotechnology stocks. Biotechnology is ranked 64 out of the 148 industries.

Overall Score - 47
BDSI has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on BDSI!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With BioDelivery Sciences International, Inc. Stock Today?

BioDelivery Sciences International, Inc. (BDSI) stock is lower by -4.04% while the S&P 500 is higher by 1.36% as of 12:04 PM on Thursday, Mar 11. BDSI has fallen -$0.16 from the previous closing price of $4.08 on volume of 875,966 shares. Over the past year the S&P 500 is up 44.16% while BDSI has fallen -1.01%. BDSI earned $0.14 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 28.37.

Click Here to get the full Stock Score Report on BioDelivery Sciences International, Inc. (BDSI) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App